NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.
| Website | http://www.neochord.com/ |
| Revenue | $10.8 million |
| Employees | 17 (8 on RocketReach) |
| Founded | 2007 |
| Address | 5402 Parkdale Dr Ste 160, Minneapolis, Minnesota 55416, US |
| Phone | +1 952-698-7800 |
| Technologies |
JavaScript
,
HTML
,
PHP
+25 more
(view full list)
|
| Industry | Retail, Medical Equipment Manufacturing, Biotechnology, Surgical Devices, Science and Engineering, Other Devices and Supplies, Medical, Health Care, Medical Device |
| Web Rank | 17 Million |
| Keywords | Mitral Valve Repair, Heart Valve Repair, Heart Valve Replacement, Medical Technology, Structural Heart Disease, Heart Valve Disease, Medical Devices, Cardiology |
| Competitors | Medtronic, Abbott, Edwards Lifesciences, Boston Scientific, Cardiovascular Systems, Inc., Stereotaxis, AtriCure, Inc., Teleflex, CRYOLIFE LIMITED, CardioFocus +36 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular NeoChord, Inc. employee's phone or email?
The NeoChord, Inc. annual revenue was $10.8 million in 2026.
Todd Berg is the CEO of NeoChord, Inc..
8 people are employed at NeoChord, Inc..
NeoChord, Inc. is based in Minneapolis, Minnesota.
The NAICS codes for NeoChord, Inc. are [33, 339].
The SIC codes for NeoChord, Inc. are [384, 38].